Skip to content

Interactive Voice-Based Administration of the PHQ-9

Interactive Voice-Based Administration of the PHQ-9

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04609267
Enrollment
40
Registered
2020-10-30
Start date
2020-11-03
Completion date
2021-07-31
Last updated
2021-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Brief summary

This study investigates a new delivery method for the Patient Health Questionnaire - 9 (PHQ-9), a clinically accepted tool for diagnosing major depressive disorder. The new tool records auditory responses to the assesment and the study will examine if the instrument is effective at capturing participant depression levels. If proven effective, future studies may investigate if the new format can be used to improve at home clinical care.

Detailed description

This study is an investigation of a new delivery system of the Patient Health Questionnaire - 9 (PHQ-9), a clinically accepted tool for diagnosing major depressive disorder. The purpose of the study is to examine if the new delivery system of the PHQ-9 is effective at capturing participant depression levels. The new version uses a Mirror device, which is similar to a smart television with a mirror interface. The device records auditory responses to the PHQ-9 through Amazon Alexa. We will be comparing the responses from the Mirror device to those given on the clinically established paper format. If proven effective at capturing depression levels of patients, future studies may investigate if the new format can be used to improve at home clinical care.

Interventions

DIAGNOSTIC_TESTPHQ-9 - Mirror format

The intervention we will be using is a new delivery system of the PHQ-9 using an Amazon Alexa equipped Mirror device. This Mirror device is similar to a smart television with a mirror interface. The device records auditory responses to the PHQ-9. We will be comparing the responses from the Mirror device to those given on the clinically established paper format.

Sponsors

Oral Roberts University
CollaboratorUNKNOWN
Oklahoma State University Center for Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

The study will be counterbalanced with no masking components

Intervention model description

This study will be a repeated measure, mixed methods design (i.e., it will contain both qualitative and quantitative components). Newly admitted patients will be asked to complete the questionnaires (i.e., PHQ-9 and the UEQ) at two different time points (i.e., Baseline and 1-month follow-up). In order to reduce or control for order effects, the procedure will be counterbalanced.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Newly admitted patients to the Oklahoma State University Behavioral Medicine Clinic

Exclusion criteria

* Vulnerable populations, such as children (i.e., minors or individuals under the legal age of consent) and individuals who are incarcerated (i.e., prisoners), will be excluded. * Individuals who are not their own guardian (i.e., those suffering from severe disabilities) will also be excluded.

Design outcomes

Primary

MeasureTime frameDescription
PHQ-9 Total ScoresImmediateMeasure for Major Depressive Disorder from questionnaire responses
User Experience SurveyImmediate26 item questionnaire tracking user experience

Countries

United States

Contacts

Primary ContactJason Beaman, D.O.
jason.beaman@okstate.edu918-561-8269
Backup ContactLuke Lawson, M.A.
luke.lawson@okstate.edu915-241-5853

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026